JP2009538823A5 - - Google Patents

Info

Publication number
JP2009538823A5
JP2009538823A5 JP2008556382A JP2008556382A JP2009538823A5 JP 2009538823 A5 JP2009538823 A5 JP 2009538823A5 JP 2008556382 A JP2008556382 A JP 2008556382A JP 2008556382 A JP2008556382 A JP 2008556382A JP 2009538823 A5 JP2009538823 A5 JP 2009538823A5
Authority
JP
Japan
Prior art keywords
chroman
tetramethyl
succinate
hydroxy
methylpentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008556382A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538823A (ja
JP5256049B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/004337 external-priority patent/WO2007098139A2/en
Publication of JP2009538823A publication Critical patent/JP2009538823A/ja
Publication of JP2009538823A5 publication Critical patent/JP2009538823A5/ja
Application granted granted Critical
Publication of JP5256049B2 publication Critical patent/JP5256049B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008556382A 2006-02-21 2007-02-21 抗癌剤 Expired - Fee Related JP5256049B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77510706P 2006-02-21 2006-02-21
US60/775,107 2006-02-21
PCT/US2007/004337 WO2007098139A2 (en) 2006-02-21 2007-02-21 Anticancer agents

Publications (3)

Publication Number Publication Date
JP2009538823A JP2009538823A (ja) 2009-11-12
JP2009538823A5 true JP2009538823A5 (https=) 2011-03-03
JP5256049B2 JP5256049B2 (ja) 2013-08-07

Family

ID=38437941

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008556382A Expired - Fee Related JP5256049B2 (ja) 2006-02-21 2007-02-21 抗癌剤

Country Status (6)

Country Link
US (2) US20080009545A1 (https=)
EP (1) EP1986635A4 (https=)
JP (1) JP5256049B2 (https=)
AU (1) AU2007217810B2 (https=)
CA (1) CA2643546A1 (https=)
WO (1) WO2007098139A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007143081A2 (en) 2006-06-02 2007-12-13 The Ohio State University Research Foundation Therapeutic agents for the treatment of lymphoid malignancies
CA2726175A1 (en) 2008-05-27 2009-12-23 Memorial Sloan-Kettering Cancer Center Models for combinatorial perturbations of living biological systems
US8461362B2 (en) 2009-04-13 2013-06-11 The Ohio State University Research Foundation Protein phosphatase 2A-activating agents
WO2010121111A1 (en) * 2009-04-17 2010-10-21 The Ohio State University Research Foundation Antiadhesion agents
US8309768B2 (en) 2010-11-29 2012-11-13 The Ohio State University Research Foundation FTY720-derived anticancer agents
US20140197449A1 (en) * 2013-01-14 2014-07-17 Electronics And Telecommunications Research Institute Semiconductor rectifier device

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680749A (en) * 1951-12-01 1954-06-08 Eastman Kodak Co Water-soluble tocopherol derivatives
US3459774A (en) * 1967-02-06 1969-08-05 Eisai Co Ltd Method of producing alpha-tocopheryl acid succinate
DE2822324C3 (de) * 1978-05-22 1981-02-26 Basf Ag, 6700 Ludwigshafen Herstellung von Vitamin-E-Trockenpulver
JPS59222415A (ja) * 1983-05-31 1984-12-14 Kuraray Co Ltd 免疫調節剤
US4751224A (en) * 1983-07-21 1988-06-14 Brown University Research Foundation Treatment of metastasis
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US6335358B1 (en) * 1995-04-12 2002-01-01 President And Fellows Of Harvard College Lactacystin analogs
WO1997024112A1 (en) * 1995-12-28 1997-07-10 Yoshitomi Pharmaceutical Industries, Ltd. External preparation
US6476004B1 (en) * 1996-07-18 2002-11-05 Mitsubishi Pharma Corporation Pharmaceutical composition
US6004656A (en) * 1997-11-14 1999-12-21 3M Innovative Properties Company Color changeable device
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
US6770672B1 (en) * 1998-09-23 2004-08-03 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
DK1115398T3 (da) * 1998-09-23 2010-08-16 Res Dev Foundation Tocopheroler, tocotrienoler, andre chroman- og sidekædederivater og anvendelser deraf
RU2263672C2 (ru) * 2000-02-11 2005-11-10 Рисерч Дивелопмент Фаундейшн Токоферолы, токотриенолы, другие хроманы и производные по боковым цепям и их применение
JP2004538304A (ja) * 2001-07-27 2004-12-24 ユニバーシティー オブ ロチェスター アンドロゲンレセプターのビタミンe阻害および前立腺癌細胞中の前立腺特異的抗原の発現
US6858227B1 (en) * 2001-11-21 2005-02-22 Sonus Pharmaceuticals, Inc. Vitamin E conjugates
US20050215531A1 (en) * 2002-05-16 2005-09-29 Thomas Baumruker Use of edg receptor binding agents in cancer
AU2004271804B2 (en) * 2003-09-12 2011-01-06 Newron Sweden Ab Treatment of disorders of the nervous system
WO2005033093A1 (en) * 2003-09-19 2005-04-14 Galileo Pharmaceuticals, Inc. 7,8-bicycloalkyl-chroman derivatives
BRPI0619894B8 (pt) * 2005-12-15 2021-05-25 Mitsubishi Tanabe Pharma Corp composto de amina e composição farmacêutica
JP5341754B2 (ja) * 2007-06-14 2013-11-13 田辺三菱製薬株式会社 アミン化合物及びその医薬用途

Similar Documents

Publication Publication Date Title
JP2009538823A5 (https=)
EP2682387A3 (en) C7-fluoro substituted tetracycline compounds
EA200701745A1 (ru) Циклопропанкарбоксамидные производные
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
EA201200763A1 (ru) Замещенные производные карбамоилметиламиноуксусной кислоты в качестве новых ингибиторов nep
EP1797878A3 (en) Benzothiazole derivatives
EP2592070A3 (en) Tetrazole-substituted arylamides
RU2006113638A (ru) Антагонисты рецептора тромбина
ATE288887T1 (de) Substituierte phenylpropionsäurederivate als agonisten des menschlichen peroxisom-proliferator-aktiverten rezeptors alpha(ppar)
JP2003528852A5 (https=)
JP2006526031A5 (https=)
EP1988898A2 (en) Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
JP2008526999A5 (https=)
CY1114803T1 (el) Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης
EA200971086A1 (ru) Фармацевтические композиции и способ лечения шизофрении
ATE512961T1 (de) Amorphes nebivolol hydrochlorid und seine herstellung
JP7036871B2 (ja) 光学活性ピラノクロメニルフェノール誘導体およびそれを含む薬学的組成物
JP2003306481A5 (https=)
EA200801529A1 (ru) Кристаллические формы 1-бензоил-4-[2-[4-метокси-7-(3-метил-1h-1,2,4-1-ил)-1-[(фосфонокси)метил]-1h-пирроло[2,3-c]пиридин-3-ил]-1,2-диоксоэтил]пиперазина
MX2009009469A (es) Nuevos benzotiofenos y benzofuranos sustituidos en la posicion 2 con heteroarilo 709.
KR20130121902A (ko) 신규 화합물 및 그 의약 용도
RU2009128970A (ru) Производные изосорбидмононитрата для лечения кишечных заболеваний
JP2011529942A5 (https=)
JP2018530617A5 (https=)